inefficient due to low cell yield from patients. In addition, hematopoietic cells are largely non-adherent and thus difficult to study over time using conventional cell culture techniques. Hence the need for new microfluidic platforms that allow the funcotional interrogation of hundreds of non-adherent single cells 25 in parallel. We demonstrate the ability to perform assays, normally performed on the macroscopic scale, within the microfluidic platform using minimal reagents and low numbers of primary cells. We investigated normal and CML stem cell responses to the tyrosine kinase inhibitor, dasatinib, a drug 30 approved for the treatment of CML. Results showed that the primary cells tolerated the microfluidic environment well and continued to proliferate as normal. Dynamic, on-chip three-color cell viability assays revealed that differences in the responses of normal and CML stem/progenitor cells to dasatinib were 35 observed even in the early phases of exposure, during which time normal cells exhibit a significantly elevated cell death rate, as compared to both controls and CML cells. Further studies show that dasatinib does, however, markedly reduces CML stem/progenitor cell migration in situ. 
Introduction
Possessing the unique ability to both self-renew as well as differentiate into multiple cell phenotypes, stem cells hold 70 enormous potential to one day provide a means of treatment for otherwise incurable diseases such as neurological disorders, diabetes, and cancer. Thus, great importance is laid upon understating the cellular mechanisms which mediate stem cell function as well as their fate. In addition to enhancing knowledge 75 of cell biology system dynamics, this would also allow the development of novel stem cell based therapeutics for degenerative disorders and malignancies.
Chronic myeloid leukemia (CML), a hematopoietic stem cell 80 (HSC) disorder, results from a reciprocal translocation between chromosome 9 and 22 [t(9;22)] leading to the formation of the BCR-ABL oncoprotein. 1, 2 HSCs are somatic cells that can differentiate into any hematopoietic cell type depending upon the conditions in the stem cell niche (i.e. the bone marrow 85 microenvironment). Despite impressive rates of remission with BCR-ABL targeted tyrosine kinase inhibitors (TKI) imatinib (Gleevec), dasatinib (Sprycel), and nilotinib (Tasigna), molecularly detectable disease remains present in the majority of patients. It is hypothesized that this molecular disease persistence results from a population of quiescent CML stem cells which are resistant to therapy. 3 The signaling pathways which enable CML 5 stem cell survival in the presence of TKIs are still unknown, but are of great interest in terms of identifying curative treatment strategies for CML as well as understanding basic stem cell biology. It is necessary, in such investigations, to examine signalling dynamics on the single cell level in order to identify 10 variations in cellular characteristics which protect certain cells, but not others, against drug-induced cell death.
Because hematopoietic cells are non-adherent, it is difficult to monitor individual cells over time using conventional, 15 macroscopic cell culture techniques. Furthermore, normal and leukemic HSCs occur in small numbers within the body and are normally located deep within the bone marrow rather than in circulation. Thus, isolating these stem cells is not trivial and obtaining quantities sufficient for bench-top scale experiments 20 remains a significant challenge in studying drug resistant cells. Many of these challenges, however, may be easily overcome through the application of microfluidic, lab-on-a-chip technology.
Microfluidic based cell culture platforms are inherently well-25 suited for working with populations of rare cell fractions. The microfluidic platform used in this investigation is based upon a platform described previously, 4, 5 and is illustrated in Figure 1 . This platform is specifically designed to accommodate hundreds of individual, non-adherent cells in parallel using a passive 30 trapping mechanism that functions not unlike capturing balls in a pachinko game (See ESI Movie 1 for video of cells loading within the device). As opposed to bench-top protocols which call for millions of cells per assay, each experiment taking place within the microdevice, with a total volume of approximately 20 35 nl, requiring of the order hundreds of cells and only minimal amounts of reagents. Given that only a few hundred thousand CD34+ hematopoietic stem cells might be collected from a single patient, performing experiments using the microfluidic platform not only provides the advantage of single cell resolution, but also 40 the ability to run several assays on the same batch of patientderived cells. In addition, the ability to sensitively control the fluidic environment on-chip has the potential to engage multiple assays simultaneously within a single device. These attributes make the application of microfluidic technology to study stem 45 cell signalling events an attractive means of gaining new insight into single cell dynamics.
Generally, microfluidic analysis of stem cells utilized cells derived from murine sources or immortalized human stem cell 50 lines. 6-9 Because immortalized cell lines possess mutations to allow continuous growth in vitro, their likeness to in vivo response to environmental influence will differ from primary cells and thus be somewhat less useful to physiologic extrapolation. In addition, data from murine cells is notoriously 55 difficult to interpret in the human context. For these reasons, we have applied our microfluidic platform to study single, patientderived CD34+ stem/progenitor cells.
The following experiments demonstrate the ability to perform 60 assays normally carried out on the macroscopic level within our microfluidic platform. We investigate patient-derived normal and CML stem cell responses to the TKI dasatinib, a small molecule inhibitor approved for treatment of imatinib resistant CML. Interestingly, not only are the assays successful in achieving the 65 predicted results, but the ability to monitor single cells over time also provides additional insight into cellular behaviors which are not apparent when using conventional techniques. In addition, media contained a high concentration five growth factor cocktail comprised of 20 ng ml -1 IL-3, 20 ng ml -1 IL-6, 100 ng ml -1 stem cell factor, 100 ng ml -1 Flt-3 ligand, and 20 ng ml -1 granulocyte-colony stimulating factor, all from Stem Cell 90 Technologies. Cells were maintained in 37 o C incubator with 5% CO 2 .
Experimental

Microfluidic Preparation
Multianalyte nanophysiometer SU-8 masters were generated 95 using soft lithographic techniques as previously detailed. 4, 5 Microfluidic devices were cast in polydimethylsiloxane (PDMS, Dow Corning) and irreversibly bonded to glass coverslips using surface treatment of plasma oxidation. Devices were sterilized/cleaned immediately prior to use by immersion for 10 100 minutes in sonic bath containing methanol. Sterile cell media was then used to flush the device and ensure that no air or methanol remained. Gas-tight syringes (Hamilton) were fitted to 50 µm inner diameter PEEK (poly-ether-ether-ketone) tubing (VICI Precision Sampling, Inc.) and controlled using microsyringe 105 pumps (Harvard Apparatus). Cells were transferred to the device accordingly: cells were aspirated directly from centrifugation pellet into the PEEK tubing (50 µM ID, 360 µM OD) which was subsequently inserted into the device inlet port. Fluid flow rates of 50 nl min -1 were sufficient to load, trap, and perifuse cells for the duration of the experiment (unless mentioned otherwise).
Fluorescence Microscopy 5
All experiments were performed using an Axio Observer Z1 microscope (Carl Zeiss), equipped with a plexiglass incubator (Pecon), temperature and CO 2 control (Pecon), and Hamamatsu Orca CCD camera. Microscope and camera were controlled via AxioVision software (Carl Zeiss).
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Division Symmetry Assay
In order to track cell division, CD34+ cells were stained with 1µM carboxyfluorescein succinimidyl ester (CFSE) as previously 15 described. 3 Alternatively, cells were incubated in 100 nM tetramethyl rhodamine methyl ester (TMRM) at 37 o C. In all cases they were allowed to rest overnight prior to assay. Bright field and CFSE fluorescence images were obtained and analyzed using Axiovision software (Carl Zeiss). 20 
Apoptosis Assay
Prior to loading into devices, cells were first incubated with 10 µM Fluo-3 (Invitrogen) for 30 minutes at 37 o C. Cells were then perfused with a solution containing 5 µg/ml propidium iodide Hoechst dye was added to the perfusing media to label nuclei.
Results and Discussion
Monitoring Stem Cell Division
The ability to observe stem cell division and proliferation is essential for two reasons: First, with regard to platform 35 validation, cell division is unlikely to proceed if cells are not in a suitable niche with the necessary nutrients. Continual cell proliferation indicates that the microfluidic environment is wellequipped to support long-term cell culture. Indeed, as shown in Figures 3A and B , both normal and CML stem cells were 40 observed to proliferate whilst trapped in the device (see ESI material for movie). Viability studies were carried out at different flow rates. The optimal flow rate was found to be between 50 and 80 nl min -1 (data not shown), with the later corresponding to an average linear velocity of 4 mm min -1 . 
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Cell Divisions Normalized Average Flourescence Intensity
Secondly, in the context of basic science, stem cells are known to be unique in their ability to both self-renew and differentiate into more specialized cell phenotypes. It is hypothesized that HSCs have the ability to undergo symmetric self-renewal divisions (increase in stem cell pool, daughter cells are both HSC), 5 asymmetric cell division (maintenance of stem cell pool; one daughter HSC and one differentiating daughter cell) and symmetric differentiation division (reduction of stem cell numbers, two differentiating daughter cells). 10, 11 In Figure 3A and B, the fluorescent markers TMRM and CFSE were used to 10 label mitochondria and cytoskeletal elements, respectively. In both cases, examining the distribution of dye during cell division revealed a symmetric partitioning of cell structure amongst daughter cells. TMRM photobleached quickly and thus it was difficult to quantify, based on fluorescence intensity alone. 15 However, in it is clear that mitochondria polarize during mitosis in such a way that approximately half remain in each daughter cell. Analysis of fluorescence intensity measurements of the highly-stable CFSE dye has been shown as a reliable means to monitor cell division. 12 
A.
CFSE in CD34+ HSCs halves with each division within the device as shown in Figure 4 . Future studies will explore the effects of manipulating the fluidic environment upon division symmetry using indicators such as CD34 and Numb to detect cell differentiation and asymmetric cell division. 5 
Dynamic Viability Assay
Dasatinib inhibits proliferation and induces apoptosis in CML progenitor and terminally differentiated cells. However, the 10 quiescent CML stem cell population is resistant to the apoptotic effect of dasatinib. 3 To better understand how some cells are able to escape dasatinib-induced cell death, we must analyze individual cells and identify mechanisms which allow for survival. 15 The microfluidic device described provides an ideal platform on which to perform parallel, high-throughput, high content drug analysis in populations of single CD34+ stem/progenitor cells. Figures 5A and 5B show normal and CML cells, respectively, 20 dynamically labelled with Annexin-V(lane c) and propidium iodide (lane d) within the device whilst exposed to 150 nM dasatinib in solution. As expected, normal cells undergo apoptosis as demonstrated by the transition from Annexin-V staining to propidium iodide (See ESI material for corresponding 25 movie). After approximately 60 minutes, cells begin to die rapidly as shown in Figure 6A , such that nearly 50% stained positive for propidium iodide after two hours. Whilst the results are consistent with that observed in other studies, 13 these results demonstrate a more rapid transition to cell death within the 30 device as compared to conventional culture techniques. This may be due to fluidic nature of the device which delivers drugs and nutrients to the trapped cells at a significant flow rate rather than relying on diffusion in static culture configurations. The drug delivery time scale in vivo may lie somewhere between the 35 diffusion limited mass transfer of static culture and the flow driven delivery of the microfluidic device. In addition, because of the continuous perfusion, the cells in the device may be more active metabolically than cells immersed in a stagnant cell culture dish. 40 The cell viability data for CML cells exposed to dasatinib are indistinguishable from those of control populations, as shown in Figure 6B . Cells that do die are only stained with propidium iodide and not Annexin-V, indicating that these cells do not 45 undergo apoptosis in response to dasatinib. This apparent resistance to drug effects might be attributed to additional activated survival pathways in the leukemic cells rendering these cells less vulnerable to the effects of the drug. These results suggest that TKI naive CD34+ CML stem/progenitor cells are 50 resistant to the effects of dasatinib from first exposure. Furthermore, this insensitivity to drug is not a consequence of prolonged drug exposure inducing the development of resistance mutations through competitive selection. The exact mechanisms which promote this TKI resistance in CML stem cell fractions 55 remain, however, unknown.
Analyzing Cell Motility Characteristics
Observation of cells within the device under control conditions revealed that CML cells are highly motile and can exert large 60 mechanical forces in order to migrate against fluid flow (as high as 80 nl min -1 ) and squeeze through gaps as small as 2 µm in width. Figure 7 shows a single CD34+ CML stem/progenitor cell (nuclei stained with Hoechst) migrating upstream through the 2 µm gaps in the cell traps (See ESI material for corresponding 65 movie). It is possible that the cells are responding to products secreted by cells upstream, or that shear stress exerted by flow activates a migratory mechanism within the cells. Regardless of the reason, the presence of dasatinib markedly reduces cell motility in CML cells. As shown in Figure 8 , only five percent of 70 CD34+ CML stem/progenitor cells exposed to dasatinib exhibited highly migratory behavior, defined as actively migrating out of a PDMS trap against fluid flow (not including random movements within the trap), compared to greater than 30% of cells in the absence of drug. 75 Dasatinib is a potent, dual Abl/Src kinase inhibitor and src kinases are known to play a role in actin organization and enhancing cell motility. 14, 15 Studies have shown that dasatinib , not including cells which exhibit random movement within the traps. Only 5% of cells exposed to dasatinib actively migrated outside of the traps compared to 30% of cells in media without drug. Student's t-test indicates migratory behaviour of dasatinib exposed population is statistically different to controls with a p-value of 0.9983. Whilst CML cells do not rapidly undergo apoptosis in response to dasatinib, the presence of the drug clearly interrupts normal migratory activity. specifically interrupts cell motility in other forms of cancer including prostate, melanoma, and Ewing sarcoma. [16] [17] [18] [19] It is likely that a similar process occurs in CML cells; a subject currently under investigation. Whilst these cells are resistant to apoptosis, dasatinib does exert a significant inhibitory effect upon 5 cell motility by blocking src kinase mediated activity. One hypothesis is that the fraction CD34+ CML stem/progenitor cells whose migratory behavior is left uninhibited by dasatinib is capable of migrating to HSC niches within the bone marrow where, in the hypoxic microenvironment, they become deeply 10 quiescent and resistant to the effects of the drug. These cells would then account for the persistent molecular disease and rapid relapse upon drug therapy withdrawal.
Conclusions
This study utilizes a microfluidic platform to analyse hundreds of 15 single cells in parallel. Previously, we demonstrated that this platform enales detection of paracrine signaling in human immune cells 4 and allows quantification of the effects of toxins upon cell mechanical activity 20 . We now show that this platform is well suited for the study of patient-derived CD34+ 20 hematopoietic stem/progenitor cells and their response to dasatinib. Successful on-chip implementation of dynamic cell proliferation, viability, and motility, techniques which are otherwise difficult to perform using conventional methods, was demonstrated. Results indicate that patient-derived stem cells 25 (both normal and CML) proliferate as normal in the constant flow-through environment. Dynamic, live cell, on-chip viability assays revealed that CML stem cells exhibit increased resistance to cell death upon exposure to dasatinib. However, despite this resistance, dasatinib clearly reduced cell migratory behaviors of 30 CML cells within the microfluidic device which indicate the drug is interrupting src kinase mediated pathways. addition, we would like to thank VIIBRE and David Schaffer for the production of device masters. Figure 5A illustrating cell normal stem/progenitor cell apoptosis in response to 150 nM dasatinib 55 exposure. Cells were preloaded with Fluo-3 AM Ester (green) prior to experiment. Annexin-V (pink) and propidium iodide (orange) were delivered along with the dasatinib in the media perfusing the device at a flow rate of 80 nl min -1 . Images were acquired every minutes for two hours. (File name: apoptosis.avi) 60 Movie 4: Cell migration. This movie corresponds to the still frames shown in Figure 7 . Here we observe a cell, labeled with Hoechst dye (blue) delivered by perfusing media, migrate upstream against an 80 nl min -1 flow rate whilst squeezing through 2um gaps between PDMS structures. Dead cells are 65 labeled with propidium iodide (orange). Images were acquired every minute for five hours. (File name: cell migration.avi)
Electronic Supplementary Information (ESI)
